CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
18.53
-0.88 (-4.53%)
At close: Dec 5, 2025, 4:00 PM EST
18.40
-0.13 (-0.70%)
After-hours: Dec 5, 2025, 7:05 PM EST
CareDx Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for CareDx stock ranges from a low of $14 to a high of $40. The average analyst price target of $26 forecasts a 40.31% increase in the stock price over the next year.
Price Target: $26.00 (+40.31%)
Analyst Consensus: Buy
* Price targets were last updated on Nov 6, 2025.
Analyst Ratings
The average analyst rating for CareDx stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 4 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 8 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $22 → $25 | Strong Buy | Maintains | $22 → $25 | +34.92% | Nov 6, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +18.73% | Sep 23, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +18.73% | Sep 12, 2025 |
| William Blair | William Blair | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Aug 26, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $19 → $14 | Hold | Maintains | $19 → $14 | -24.45% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
380.87M
from 333.79M
Increased by 14.11%
Revenue Next Year
426.57M
from 380.87M
Increased by 12.00%
EPS This Year
0.68
from 0.93
Decreased by -27.39%
EPS Next Year
0.92
from 0.68
Increased by 36.62%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 393.3M | 449.7M | ||
| Avg | 380.9M | 426.6M | ||
| Low | 361.8M | 391.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 17.8% | 18.1% | ||
| Avg | 14.1% | 12.0% | ||
| Low | 8.4% | 2.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.76 | 1.20 | ||
| Avg | 0.68 | 0.92 | ||
| Low | 0.47 | 0.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -18.7% | 77.3% | ||
| Avg | -27.4% | 36.6% | ||
| Low | -49.4% | 5.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.